A type of bovine herpesvirus, BHV-1.3, causes encephalitis in calves, whereas BHV-1.1 causes respiratory disease. Three colostrum-deprived calves and two colostrum-fed calves were inoculated with BHV-1.3 by intranasal aerosolization. Two colostrum-deprived calves were inoculated with BHV-1.1 by intranasal aerosolization. BHV-1.3-inoculated calves demonstrated severe encephalitis with minimal respiratory lesions, and BHV-1.1 -inoculated calves demonstrated severe respiratory lesions and no clinical signs of neurologic disease. Calves fed colostrum that contained virus neutralizing antibodies were protected against neurologic disease. Colostrum-fed BHV-1.3-inoculated calves did not develop disease although they did become infected; virus was shed in respiratory secretions for 10-1 3 days postinoculation, similar to infected colostrum-deprived calves. BHV-1.3 was reactivated from a latent state from one colostrum-fed calf after administration of dexamethasone 60 days postinoculation. Histopathologic examination of the three colostrum-deprived BHV-1.3inoculated calves revealed severe lesions of encephalitis. One of the two BHV-1.1-inoculated calves had one focal lesion of encephalitis. Virus was isolated from brain tissue of colostrum-deprived BHV-1.3-inoculated calves and from one BHV-1.1 -inoculated calf. Immunohistochemical staining for BHV-1 antigen was observed in neurons from the colostrum-deprived BHV-1.3-inoculated calves.
Viruses known to cause encephalitis in cattle include rabies, pseudorabies, and malignant catarrhal fever. Natural outbreaks of meningoencephalitis due to bovine herpesvirus 1 (BHV-1) have been reported, as have experimental infections using viruses isolated from these ~~t b r e a k~.~,~.~J~J~.~~,~~ Bovine herpesvirus 1 is known to cause respiratory disease (infectious bovine rhinotracheitis), abortions, genital tract lesions (infectious pustular vulvovaginitis), and conjunctivitis in cattle. Neurologic signs associated with BHV-1 infections have been described primarily in young animals, usually 2-1 6 months of age. Reported neurologic signs with BHV-1 infection include tremors, circling, bruxism, vestibular signs, nystagmus, and recumbency followed by convulsions and paddling. Mortality is usually 1009'0.~J~J~ Strains of BHV-1 that have been isolated from cattle exhibiting neurologic signs have been designated BHV-1.3 or bovine encephalitis herpesvirus (BEHV).5,21.28 Antigenic differences have been recognized between major glycoproteins of the neurologic form (BHV-1.3) and respiratory form (BHV-1.1) of bovine herpesvirus.1,4J3 This study was performed to document the production of neurologic disease by infecting colostrum-deprived calves with an isolate of BHV-1.1 from a case of respiratory tract disease and a n isolate of BHV-1.3 from an outbreak of bovine encephalitis.l* The BHV-1.3 isolate is purported to be the only such neurotropic BHV-1 isolate from the United States at this time. Colostrum-fed calves were also used to determine if maternal antibodies or another factor from BHV-1.1 -vaccinated cows provided protection against clinical signs of BHV-1.3-induced encephalitis.
Materials and Methods

Calves
Holstein calves were obtained from a local dairy at birth and transported immediately to isolation facilities. Calves were fed a nonmedicated milk replacer (Purina Nurse Chow No. 100, Purina Mills, St. Louis, MO) at 10°/o of body weight divided into two equal feedings per day. Prior to receiving milk replacer, each colostrum-fed calf received 1 liter of pooled colostrum per 0s at birth and again 12 hours later. Colostral levels ofantibody to BHV-1.1 and BHV-1.3 were measured. Calves in the dexamethasone challenge group were also fed water ad libitum, alfalfa hay, and a 14% calf starter. Colostrum-deprived calves were administered ceftiofur sodium (Naxcel, Upjohn, Kalamazoo, MI) at 1.1 mg/kg once daily by intramuscular injection for the duration of the study. All calf care was in accordance with the "Guide for the Care and Use of Laboratory Animals." 
Experimental design
Three colostrum-deprived calves (Nos. 1-3) and two colostrum-fed calves (Nos. 6, 7) were inoculated with BHV-1.3. Two colostrum-deprived calves (Nos. 4, 5 ) were inoculated with BHV-1.1 (Table I) . Colostrum-deprived calves were euthanatized at onset of neurologic disease or when severe respiratory disease developed. At 60 days postinoculation, the two surviving colostrum-fed calves were given 20 mg of dexamethasone (Dexameth-A-Vet, Anpro Pharmaceutical, Arcadia, CA) intravenously for 5 days. Calves administered dexamethasone were euthanatized 12 days after the first dexamethasone injection.
Cell culture and virus
Primary bovine turbinate (BT) cells were cultured in Eagle's Minimum Essential Medium (MEM) with Earle's salts, buffered with 25 mM HEPES and 26.2 mM sodium bicarbonate, and supplemented with 10% fetal bovine serum, 50 units/ml penicillin, 50 yg/ml streptomycin, and 10 yg/ml tylosin. Cultures were incubated at 37 C in 5% CO,. Tissue culture flasks were inoculated with either a previously characterized strain (No. 10902) of BHV-1.1 recovered from the respiratory tract of a case of bovine rhinotracheitis1° or a strain of BHV-1.3 (No. EC-I) recovered from the brain of a calf with encephalitis in an outbreak in Texas.'* Tissue culture supernatant fluid was collected when cytopathic effect (CPE) reached 100%.
Inoculation of calves
Calves were inoculated intranasally by aerosolization (DeVilbis model 50 nebulizer, Devilbis Co., Somerset, PA) with 1 ml of inoculum per nostril as described previously.I0 Inoculum for BHV-1.3 infected calves (Nos. 1-3, 6, 7) contained 2 x 106 tissue culture infective doses (TCID,,), and inoculum for BHV-1.1 -inoculated calves (Nos. 4, 5 ) contained 5 x 1 O6 TCID,,. Calves were inoculated once (day 0).
Monitoring and sample collection
Calves were monitored daily for body temperature, respiratory rate, and clinical signs of disease. Serum samples were collected on days 0, 3, 6, 9, 12, 2 1, 60, and 67. Nasal swabs were collected daily from all calves for 2 weeks, once at 3 weeks, and daily after dexamethasone administration (calf Nos. 6, 7). The nasal mucosa was scraped vigorously with a cotton-tip swab, which was then transferred to 2 ml of MEM and frozen at -70 C before titration. Whole blood was taken from colostrum-fed calves (Nos. 6, 7) for complete blood counts on days 1, 3, and 5 after initiation of dexamethasone administration.
Nasal swab specimens (0.1-0.2 ml) were inoculated onto monolayered BT cells in four-well tissue culture plates. After allowing 1-2 hours for adsorption, medium was replaced and cultures were incubated at 37 C with 5% CO, in a humidified chamber until CPE appeared or for a maximum of 2 weeks.
Positive specimens were quantitated by inoculating serial 10fold dilutions onto BT cells in 96-well plates and calculating the TCID,,. Antibody titers to BHV-1.1 and BHV-1.3 were measured by serum neutralization technique.23 Radial immunodiffusion was used to measure IgG levels in serum from colostrum-fed calves on day 2.
Postmortem sampling
Calves were euthanatized by a barbiturate (Euthanasia 6, Anthony Products Co., Arcadia, CA) overdose administered intravenously. Complete necropsies were performed immediately after death. Tissues were collected for virus isolation, light microscopic examination, and immunohistochemical evaluation. Twenty areas of neural tissue from colostrumdeprived BHV-1.3-inoculated calves (Nos. 1-3) were examined microscopically. These areas included right and left dorsolateral cerebral cortex; anterior cerebral cortex (intersection of first and second quarters); posterior cerebral cortex (intersection of third and fourth quarters); midbrain at the level of cranial nerve 111; brain stem at the levels of cranial nerves V, IX, and XII; cerebellum; and cervical spinal cord. Eye, lung, bronchial and mesenteric lymph node, pharyngeal tonsil, trachea, liver, spleen, kidney, and adrenal gland samples were also collected. Anterior cerebral cortex, midbrain and hippocampus, brain stem, and cerebellum of colostrumfed BHV-1.3-inoculated calves (Nos. 6, 7) and colostrumdeprived BHV-I. 1 -inoculated calves (Nos. 4, 5 ) were sampled. Lung, trachea, pharyngeal tissue, and bronchial lymph nodes of BHV-1.1-inoculated calves (Nos. 4, 5 ) were also collected. All samples were collected using sterile technique and processed for histopathologic examination and virus isolation. Tissues for histopathologic examination were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (HE). Lung tissue samples from three calves (Nos. 3-5) with signs of bronchopneumonia were submitted for bacterial culture. Tissue samples for viral isolation were processed by preparing a 20% (wt/vol) homogenized suspension and freezing at -70 C. Before inoculation of tissue culture cells, cellular debris was removed by centrifugation.
Indirect immunoperoxidase staining using the avidin-biotin-peroxidase complex procedure was used to detect antigens for BHV-1.3 and BHV-1.1 in formalin-fixed tissues as previously described,*' using cross-reactive monoclonal antibody H2 at a dilution of 1 : 800.9
Viral polypeptide analysis
Analysis of viral polypeptides was used to distinguish BHV-1.1 and BHV-1.3. Radiolabeling of virus-specific polypeptide, immunoprecipitation, and sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed as Vet Pathol 3 1:3, I994 described
Monoclonal antibodies (MAbs) used for immunoprecipitation were specific for the gIII glycoproteins (MAb 1 D629) and for the gIV glycoproteins (MAb 1 1 0 2 9 of the viruses.
Results
Clinical observations
Colostrum-deprived calves inoculated with BHV-1.3 (calf Nos. 1-3) first displayed signs of serous nasal discharge on day 7 postinoculation; signs progressed to a mucopurulent discharge. Febrile response was usually observed by day 2 postinoculation (Fig. 1 ). Anorexia was noted in calf No. 2 before it displayed neurologic signs. Neurologic signs in calf No. 2, apparent by day 9 postinoculation, were characterized initially by muscle trembling, circling to one side (left), jaw chomping, ataxia, and sporadic closing of the left eyelid. The calf then spastically moved its left leg, fell over into lateral recumbency, and experienced seizurelike episodes, paddling, and opisthotonos. These signs were progressive, and the calf was euthanatized within 2 hours. Calf No. 1 experienced seizure episodes immediately before it died on day 10; no signs prior to these were observed. Calf No. 3 was euthanatized on day 10 postinoculation because of severe bronchopneumonia; no neurologic signs were observed.
Colostrum-deprived calves inoculated with BHV-1.1 (calf Nos. 4, 5) displayed respiratory signs starting on day 2 postinoculation. Clinical signs included a serous nasal discharge followed by slight depression, dyspnea, and some coughing. Calf No. 4 progressively deteriorated to severe dyspnea and depression, lateral recumbency, and weakness and was euthanatized on day 7 postinoculation. Calf No. 5 became dyspneic, depressed, and anorectic and was euthanatized on day 11 postinoculation. Calf Nos. 4 and 5 both had elevated rectal temperatures (up to 40.8 C).
Colostrum-fed BHV-1.3-inoculated calves (Nos. 6, 7) did not display any clinical signs of respiratory or neurologic disease prior to dexamethasone (Dx) administration. Dexamethasone administration starting at day 60 postinoculation resulted in a mild cough in both calves and lethargy in one calf coincident with an elevated rectal temperature.
Laboratory findings
Serum immunoglobulin levels from colostrum-deprived calves (Nos. 1-5) indicated failure of passive transfer, and serologic evaluation confirmed the absence of antibodies to BHV-1. These calves did not seroconvert to BHV-1 before euthanasia or death (days 7-1 1 postinoculation). Neutralizing antibody titers against BHV-1.1 and BHV-1.3 on pooled colostrum samples were 1 : 1,024. Colostrum-fed calves (Nos. 6, 7) demonstrated seroconversion to BHV-1.3 after co- lostrum consumption. Serum neutralizing titers on day 1 were 1 : 256/5 12 and declined to 1 : 16/32 by 60 days postinoculation.
After inoculation, shedding of virus in nasal secretions ( Fig. 2A) was monitored for BHV-1.3-and BHV-1.1 -inoculated calves. The BHV-1.3-inoculated calves (Nos. 1,2) shed approximately 1 00-fold less virus than did the BHV-1.1-inoculated calves (Nos. 4, 5). Virus was isolated from nasal swabs from BHV-1.3-inoculated colostrum-fed calves (Nos. 6, 7) for 2-3 weeks postinoculation at levels similar to those of the BHV-1.3-inoculated colostrum-deprived calves (Fig. 2B ). Virus was also isolated from respiratory tract tissues (lung, bronchial lymph node, trachea, tonsil) from calf Nos. 1-5 at necropsy. Virus titers were higher in respiratory tract tissues from BHV-1.1 -inoculated calves (Nos. 4,5) (2 x 105-2 x lo6 TCID,,/ml) than in those from BHV-1.3-inoculated calves (Nos. 1-3) (10'-2 x 1 O5 TCID,,/ml) ( Virus was isolated from several areas of the brain tissue of calf Nos. 1-4 ( Table 2 ). The BHV-1.3-inoculated calves (Nos. 1-3) had higher quantities of virus and from more locations than did the BHV-1.1411- oculated calves (Nos. 4, 5). The widespread presence of virus in the brain correlated with severe histopathologic lesions characteristic of encephalitis. One BHV-1.1 -inoculated calf (No. 5 ) had no virus isolated from the brain, although there was a mild focal lesion of encephalitis. Polypeptide differences confirmed the viral isolates from brain of calf Nos. 1-3 as BHV-1.3 and the isolate from brain of calf No. 4 as BHV-1.1.
Tissues from calf Nos. 1-5 were examined for BHV-1 antigen by immunoperoxidase staining. Tissue antigen to BHV-1 was detected by immunoperoxidase staining in nervous system tissue only in calfNos. 1-3. Antigenpositive cells were located throughout the brain (Table  3 , Fig. 3 ). Antigen was also detected in lung, bronchial lymph node, tonsil, trachea, liver, and kidney tissues At 6 0 days postinoculation, BHV-1.3-inoculated colostrum-fed calves (Nos. 6, 7) were administered Dx for 5 days to induce immunosuppression and possibly reactivate BHV-1.3 from a latent state. Complete blood counts (CBC) on samples taken on days 2 and 4 following start of Dx administration indicated stress leukograms. Lymphopenia alone (calf No. 7) or with leukopenia (calf No. 6) characterized CBCs on day 7 after initiation of Dx treatment. One calf (No. 7) shed BHV-1.3 (Fig. 4) in nasal secretions for 6 days after Dx administration.
Gross and light microscopic findings
There were no gross lesions in two of three colostrum-deprived calves inoculated with BHV-1.3 (calf Nos. 1, 2); the other colostrum-deprived BHV-1.3inoculated calf (No. 3) had severe necrotizing bronchopneumonia. Histologic lesions in brains of calf Nos.
1-3 consisted of widespread nonsuppurative meningoencephalitis characterized by neuronal necrosis, gliosis, disruption of the neuropil, and lymphocytic perivascular cuffing (Figs. 5,6) . In some sections of cerebral cortex, inflammatory cells formed broad bands running along white matter tracts. Lesions were not symmetrical in distribution or severity, and there was great variation among calves in the pattern of lesions (Table  4 ). Lung of calf No. 3, which had severe necrotizing suppurative bronchopneumonia on gross examination, had multiple areas of liquefactive necrosis in which bacterial colonies were present. Bronchioles contained amorphous eosinophilic material, degenerate neutrophils, mucus, and debris. Surrounding alveoli contained neutrophils, macrophages, and proteinaceous fluid. The gross and histopathologic lung lesions of calf * 0 = no virus detcted (< 1 TCID,,/ml); low = 10'-2 x 10' TCID,,/ml; mod = 2 x 103-2 x 10, TCID,,/ml; hi = 2 x 105-2 Pathol 31:3, 1994 recent study demonstrated cross-protection in calves vaccinated against a respiratory strain and challenged with a neurologic strain of BHV-1 .5 Studies with herpes simplex virus in mice have demonstrated protection against viral encephalitis by passively administered antibodies.Ig Attempts to reactivate BHV-1.3 from a latent state by Dx administration were successful; virus was recovered from nasal swabs of calf No. 7. Virus was recovered on day 6 post-Dx injection and for 6 subsequent days. Prior to that time, virus had not been isolated from nasal swabs since day 14 postinoculation, suggesting that the virus recovered was reactivated from a latent state. However, the Dx-treated calves (Nos. 6, 7) did not demonstrate neurologic signs or lesions in their brain tissue. In previous reports, reactivation of BHV-1 by single or multiple doses of Dx also occurred without clinical ~i g n s .~~,~O Others have reported that the ability to reactivate and isolate virus is dependent upon the duration of initial viral shedding (replication) post-BHV i n o c~l a t i o n .~~ Demonstration of virus in the brains of colostrumdeprived calves (Nos. 1-3) inoculated with BHV-1.3
confirmed that this strain (Texas) of BHV-1.3 reproduced the neurologic form of bovine herpesvirus using a natural route of infection. Respiratory signs were not prominent in colostrum-deprived calves inoculated with BHV-1.3, although virus was isolated from areas other than the central nervous system (CNS). BHV-1.3 has been recovered from CNS tissue, liver, bone marrow, and an aborted fetus of affected animals.26 Similar to previous reports of BHV-1.3 neurologic disease,6.26 calves in the current study also displayed signs of lacrimation and/or nasal discharge prior to neurologic symptoms. Histologically, brain lesions in calf Nos. 1-3 were similar to those described in previous reports of infections due to other isolates of BHV-1.3. These lesions included a nonpurulent meningitis, perivascular cuffing, neuronal necrosis, and g l i~s i s .~,~~,~~ No eosinophilic intranuclear inclusion bodies or areas of malacia were observed as described in other report^.^,^ In the initial description of the Texas isolate of BHV-1.3, two calves experimentally inoculated intravenously also developed diarrhea, and pinpoint areas of necrosis were observed in the liver and kidney.12 In addition, one calf developed a fibrinopurulent polyarthritis, and the other developed a mild focal tracheitis and bronchitis. Only a mild tracheitis was observed in the current study (calf Nos. 1, 2), despite direct inoculation by aerosol. Necrotizing pneumonia, observed in calf No. 3, was most likely secondary to aspiration of milk during feeding rather than secondary to BHV-1.3 infection, because virus titers in the respiratory tract tissue were low in this calf as compared with titers in the BHV-1.1 -inoculated calves.
Severe clinical and histopathologic signs of respiratory disease and high levels of respiratory tract virus were observed in colostrum-deprived calves inoculated with BHV-1.1 (calf Nos. 4, 5). Calf No. 5 had one lesion of focal encephalitis, and virus was isolated from two areas of brain from calf No. 4. Although respiratory signs were more pronounced in these calves, it appears that BHV-1.1 is capable of spreading to the CNS. Because of euthanasia of the BHV-1. l-inoculated calves on days 7 and 11, analysis of the CNS for virus or histopathologic lesions may not have adequately represented the extent of virus infection in the brain. Further studies, perhaps with more appropriate antibiotic administration to prevent secondary bacterial pneumonia, are necessary. Previous experimental studies of BHV-1.1 have not documented central nervous system involvement, although the virus has been recovered sporadically from brain tissue in cases of disseminated neonatal BHV-1 i n f e~t i o n . l~J~,~~ Seven of eight strains isolated from bovine encephalitis cases in Argentina were of BHV-1.3, and the remaining isolate had molecular characteristics of BHV-1.1 . 21 Immunohistochemical examination of tissues for BHV-1 antigens is helpful in identification and/or verification of infection. The amounts of virus isolated from brain tissue did not correlate with extent of areas of positive antigen detection. Areas of brain tissue with severe histopathologic lesions were more likely to be positive for BHV-1 antigen.
The neuropathologic mechanism by which the brain is infected is presumed to be via the trigeminal nerve,2 although a viremic state has been suspected.14 The current study did not attempt to document viremia. The multifocal distribution (Table 2) 
